ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Nobel Prize Awarded to Blobel for Research On Protein Signaling; Work Funded By NIH

October 15, 1999

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003

Ovarian Cancer Screening Unnecessary for Most Women, Consensus Panel Says

April 15, 1994

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

NIH Alternative Medicine Officer Under Fire For Proposed RFA In Homeopathy, Acupuncture

February 26, 1993

Some Of Show’s Screening Messages Not Widely Accepted.

September 12, 2008